Nuveen Asset Management, LLC Neurocrine Biosciences Inc Transaction History
Nuveen Asset Management, LLC
- $345 Billion
- Q3 2024
A detailed history of Nuveen Asset Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 345,577 shares of NBIX stock, worth $50.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
345,577
Previous 347,493
0.55%
Holding current value
$50.7 Million
Previous $47.8 Million
16.83%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding NBIX
# of Institutions
631Shares Held
93.9MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.08 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.47 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$756 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$378 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$274 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...